TriLink BioTechnologies
The new technologies helping biopharmaceutical trailblazers accelerate progress from research to market
Getting new drugs out of the research phase, and into clinical studies and commercialization, is an odyssey in quality control, regulatory deftness and patient safety. This can be particularly cumbersome for emerging therapies like genomics and mRNA – but innovation is helping to break down barriers